AMRN Related New Coverage

Mar 20, 2013 11:17 AM UPDATE: Chardan Capital Starts Amarin Corporation (AMRN) at Neutral, Chance of Strategic Deal Low

Nov 27, 2012 11:30 AM UPDATE: Citi Starts Amarin (AMRN) at Buy; Sees Favorable Risk/Reward Even if 'Going Alone' on Vascepa

Oct 9, 2012 12:28 PM Amarin (AMRN) Rated Buy at Roth Capital, Sees "Blockbuster Potential" for Vascepa

Jun 12, 2012 08:54 AM Aegis Starts SGYP, IRWD, AMRN, MDVN at Buy, PLX at Hold

Apr 30, 2012 06:58 AM Citi Starts Amarin Corporation (AMRN) at Buy

Apr 20, 2012 08:03 AM JPMorgan Starts Amarin (AMRN) at Overweight, Sets $22 Price Target

Mar 27, 2012 12:51 PM Wedbush Assumes Coverage on Amarin Corporation (AMRN) at Outperform; Patent Application Resolves Overhang...Takeover Anyone?

Aug 1, 2011 12:45 PM Monness, Crespi, Hardt Starts Amarin (AMRN) at Neutral

Jun 14, 2011 09:03 AM Morgan Joseph Starts Amarin Corporation (AMRN) at Buy; Fishing Out Triglycerides, Knocking Down Cholesterol

Feb 2, 2011 08:05 AM Jefferies Starts Amarin Corporation (AMRN) at Buy

Dec 23, 2010 10:58 AM Lazard Capital Starts Amarin Corporation (AMRN) at Buy

Nov 11, 2010 07:52 AM Canaccord Genuity Starts Amarin Corporation (AMRN) at Buy

Jul 20, 2010 11:12 AM Wedbush Starts Amarin (AMRN) at Outperform, $5 Price Target; Calls Co. A 'High Priority Takeover Target'

Apr 27, 2010 10:02 AM Leerink Swann Initiates Coverage on Amarin (AMRN) with an Outperform

Nov 6, 2008 10:52 AM Rodman & Renshaw Initiates Coverage on Amarin Corp (AMRN) with a Market Outperform